WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (31)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Russo-Neustadt, A.
Right arrow Articles by Cotman, C. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Russo-Neustadt, A.
Right arrow Articles by Cotman, C. W.

 Previous Article  |  Next Article 

Volume 17, Number 14, Issue of July 15, 1997 pp. 5573-5580
Copyright ©1997 Society for Neuroscience

Adrenergic Receptors in Alzheimer's Disease Brain: Selective Increases in the Cerebella of Aggressive Patients

Received Feb. 18, 1997; revised April 25, 1997; accepted May 8, 1997.

Amelia Russo-Neustadt and Carl W. Cotman

Institute for Brain Aging and Dementia, University of California, Irvine, California 92697-4540

In this study, the distribution and concentration of beta 1, beta 2, and alpha 2 adrenergic receptors were examined in the frontal cortex, hypothalamus, and cerebellum of Alzheimer's disease (AD) and age-matched control human brains by receptor autoradiography. The purpose of this study was to detect changes in adrenergic receptor concentrations in key areas of the brain known to affect behavior. For these studies, [125I]iodopindolol ([125I]IPIN) was used to visualize total beta  adrenergic sites (with ICI-89,406 and ICI-118,551 as subtype-selective antagonists to visualize beta 2 and beta 1 receptors, respectively). [3H]UK-14,304 was used to localize the alpha 2 sites. Essentially no significant difference in adrenergic receptor concentration was found between total AD cases taken together and control patients. It was found, however, that there were important distinctions within the AD group when cases were subdivided according to the presence or absence of aggression, agitation, and disruptive behavior. Aggressive AD patients had markedly increased (by ~70%) concentrations of alpha 2 receptors in the cerebellar cortex compared with nonaggressive patients with similar levels of cognitive deficit. The levels of cerebellar alpha 2 receptors in aggressive AD patients were slightly above the healthy elderly controls, suggesting that these receptors are preserved and perhaps increased in this subgroup of AD. beta 1 And beta 2 adrenergic receptors of the cerebellar cortex showed smaller but significant (~25%) increases in concentration in aggressive AD subjects versus both nonaggressive AD patients and controls. No significant differences were found in adrenergic receptor concentrations within the frontal cortex or hypothalamus. These results point out the importance of distinguishing behavioral subgroups of AD when looking for specific neurochemical changes. These autoradiographic results may reflect the importance of the cerebellum in behavioral control.

Key words: autoradiography; dementia; aggression; behavioral disorder; receptor localization; frontal cortex; hypothalamus




This article has been cited by other articles:


Home page
Arch NeurolHome page
N. Scarmeas, J. Brandt, D. Blacker, M. Albert, G. Hadjigeorgiou, B. Dubois, D. Devanand, L. Honig, and Y. Stern
Disruptive Behavior as a Predictor in Alzheimer Disease
Arch Neurol, December 1, 2007; 64(12): 1755 - 1761.
[Abstract] [Full Text] [PDF]


Home page
GerontologistHome page
C. R. Kovach, Y. Taneli, P. Dohearty, A. M. Schlidt, S. Cashin, and A. L. Silva-Smith
Effect of the BACE Intervention on Agitation of People With Dementia
Gerontologist, December 1, 2004; 44(6): 797 - 806.
[Abstract] [Full Text] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
N. Herrmann, K. L. Lanctot, and L. R. Khan
The Role of Norepinephrine in the Behavioral and Psychological Symptoms of Dementia
J Neuropsychiatry Clin Neurosci, August 1, 2004; 16(3): 261 - 276.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
N. Herrmann, K. L. Lanctot, G. Eryavec, and L. R. Khan
Noradrenergic Activity is Associated with Response to Pindolol in Aggressive Alzheimer's Disease Patients
J Psychopharmacol, June 1, 2004; 18(2): 215 - 220.
[Abstract] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
K. L. Lanctôt, N. Herrmann, and P. Mazzotta
Role of Serotonin in the Behavioral and Psychological Symptoms of Dementia
J Neuropsychiatry Clin Neurosci, February 1, 2001; 13(1): 5 - 21.
[Abstract] [Full Text]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
W. C. Groves, J. Brandt, M. Steinberg, A. Warren, A. Rosenblatt, A. Baker, and C. G. Lyketsos
Vascular Dementia and Alzheimer's Disease: Is There a Difference?: A Comparison of Symptoms by Disease Duration
J Neuropsychiatry Clin Neurosci, August 1, 2000; 12(3): 305 - 315.
[Abstract] [Full Text]


Home page
Am. J. PsychiatryHome page
C. G. Lyketsos, C. Steele, E. Galik, A. Rosenblatt, M. Steinberg, A. Warren, and J.-M. Sheppard
Physical Aggression in Dementia Patients and Its Relationship to Depression
Am J Psychiatry, January 1, 1999; 156(1): 66 - 71.
[Abstract] [Full Text]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-